Documente Academic
Documente Profesional
Documente Cultură
Mechanisms of disease
Anne JOUTEL
?
SMC/pericytes
a-Notch3ECD
Notch3ECD / GOM
+/+ +/+
Migraine/ CSD
nd nd +
Lacunar infarcts
(?) 7% -
C57BL/6
+/+
nd
-/nd
129/BL6
nd/+
nd
-/nd
129/BL6
nd/+
nd
-/nd
FVB
+/+
nd
-/nd
a-N3ECD
F
Myelin- associated vacuoles (%)
Vacuoles (%)
a-MBP a-NF
A- CBF autoregulation
B- Functional hyperemia
C- intraparenchymal arterioles
Joutel et al, J. Clin Invest. 2010 Dabertrand, Joutel & Nelson, in preparation
Notch3ECD deposits
12 Cerebral hypoperfusion
20 months
Key issues
?
SMC/pericytes
a-Notch3ECD
Notch3 plays a key role in the structure and function of small arteries
Ligands (Jagged1)
Arterial SMC differentiation and maturation Arterial tone Transcriptional activator: Notch3, Grip2, Nrip2, HeyL, Kv1.5...
RBPJ GTGGGAA
Domenga et al, Genes & Dev 2004 Prowler et al, PNAS 2007 Belin de Chantemle et al, ATVB 2008 Fouillade et al, Cardiovasc Res. 2012 Fouillade et al, ATVB 2013
A few CADASIL mutations in the ligand binding domain abolish Notch3 activity
15
% of Mutations
10
Ligand binding
34 EGFR
RBPJ-LacZ
Knock-in mice with the archetypal Arg170/169Cys mutation retain normal Notch3 signaling in the brain arteries A
Elimination of wildtype Notch3 in TgN3R169C mice does not exacerbate white matter lesions
Key issues
?
SMC/pericytes
a-Notch3ECD
Ligands (Jagged1)
Notch3C428S
S1
TghN3WT,N3+/+
S2
TghN3C428S,N3+/+
TghN3C428S,N3-/-
S3
RBPJ
SMC
Joutel et al, JCI 2000 Ishiko et al, Acta Neuropathol 2006 Monet-Leprtre et al, Brain 2013
Notch3ECD
RIPA
SDS 2%
laemmli+ me
S1
S2
S3
Nano LC MS/MS
Monet-Leprtre et al, Brain 2013
TIMP3 accumulates in the brain vessels of mouse models and patients with CADASIL
nonTg
TgN3R169C
control
patient
a-Notch3ecd
a-TIMP3 a-SMA
A a-TIMP3
control
patient
patient
patient
patient
a-TIMP3
a-N3ecd
merge
a-TIMP3
a-Vtn
a-N3ecd
merge
merge patient
(1)
(2)
(3)
(4)
WT
Mutant Notch3
TIMP3
Vitronectin
Others
Key issues
?
SMC/pericytes
a-Notch3ECD
The early (potentially causative) cerebrovascular changes? Notch3 receptor malfunction? Mechanisms of Notch3ECD/GOM deposits formation? Novel function gained by mutant Notch3?
TIMP3
TIMP4
B
a-TIMP3
30-kDa 20-kDa
a-SMA
40-kDa
non-Tg TgBAC-TIMP3(2)
8 7 6 5 4 3 2 1 0 non-Tg TgBAC-TIMP3
B
Myogenic responses (% passive diameter)
pressure
Superfusion of TIMP3, but neither of TIMP1 nor of TIMP2, impairs neurovascular function
A B Notch3R169C TIMP3
?
MMPs C
40
TIMPs
D
40
CBF (% increase)
30 20 10 0
CBF (% increase)
Whisker Ringer
n=5
30 20 10 0
ACh
Adenosine Timp2(1mg/mL)
Whisker Ringer
n=5
ACh
Adenosine Timp1(1mg/mL)
ADAM-17 (TACE) superfusion ameliorates neurovascular dysfunction in TgTIMP3 and TgNotch3R169C mice
A Notch3R169C TIMP3 B
?
ADAM17 (TACE) C D
Notch3ECD deposits
Cerebrovascular dysfunction
ALUMNI B. Bardot (post-doc), S. Cleophax (tech Staff), C. Dussaule (MSc student), P. Fardoux (PhD student), C. Fouillade (PhD student), P. Lacombe (Scientist), B. Lemaire (tech Staff), M. Monet-Leprtre (PhD student, post-doc), M. Fouillot-Pancha (tech Staff), M. Riani (MSc student)
Collaborators
I Haddad & J. Vinh (ESPCI, Paris, France) M. Cohen-Tannoudji & C. Babinet+ (Pasteur Institute, Paris, France) L Mesnard & E. Rondeau (Inserm, Paris, France) D. Henrion (Inserm, Angers, France) M Dewerchin (VIB, Leuven, Belgium) C. Gosele & N. Hbner (MDC Berlin, Germany) C. Haffner & M. Dichgans (Ludwig-Maximilians-University, Munich, Germany) H. Stoehr & B. Weber (Regensburg University, Germany) S. Christensen, J. Stavenhagen & J. Pedersen (Lundbeck, Valbi, Denmark) T. Gridley (Jackson Lab, Bar Harbor, USA) K. Takamiya & R. Huganir (The Johns Hopkins University School of Medicine, Baltimore, USA)F. Cenk Ayata & M. Moskowitz (Harvard Medical School, Charlestown, USA) Dabertrand & MT Nelson (University of Vermont, Burlington, USA) Brain banks : S. Turbant (GIE-NeuroCeb, Paris), JJ. Hauw (CHU Pitie-Salpetrire, Paris), F. Chapon (CHU Caen), C. Godfraind (Clinique St Luc, Bruxelles, Belgium), H. Kalimo (University of Turku, Finland), T. Arzberger (Brain Net, Munich, Germany) Facilities: C. Martin (Transgenic Mouse facility, TAAM, Villejuif), C. Thibault (MicroArray facility, IGBMC, Illkirch), J.P. Rio (Electron microscopy facility, IFM, Paris) Funding : National Institute Health (NINDS), European Community (Marie Curie ITN), Agence Nationale de la Recherche, Fondation Leducq, H Lundbeck A/S, Inserm, Universit Paris 7, Gis Maladies Rares, Fondation pour la Recherche Mdicale, Fdration pour la Recherche pour le Cerveau